Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry.
| Image |  |
|---|---|
| Description | scientific article published on 25 March 2017 |
| Author/s |
author: Henning Kleine Jan Hettinger |
| Publication date | May 25, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |